共 23 条
[1]
Gregoriadis, Liposome Technology, Vols. 1, 2 and 3, (1984)
[2]
Gregoriadis, Liposomes as Drug Carriers: Recent Trends and Progress, (1988)
[3]
Ostro, Liposomes: from Biophysics to Therapeutics, (1987)
[4]
Roerdink, Daemen, Bakker-Woudenberg, Storm, Crommelin, Scherphof, Therapeutic utility of liposomes, Drug Delivery Systems: Fundamentals and Techniques, Ellis Horwood Series in Biomedicine, pp. 66-80, (1987)
[5]
Machy, Leserman, Research in Liposomes in Cell Biology and Pharmacology, (1987)
[6]
Storm, Van Bloois, Brouwer, Crommelin, The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation, Biochim. Biophys. Acta, 818, pp. 343-351, (1985)
[7]
Storm, Roerdink, Steerenberg, De Jong, Crommelin, Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model, Cancer Res., 47, pp. 3366-3372, (1987)
[8]
Steerenberg, Storm, De Groot, Claessen, Bergers, Franken, Van Hoesel, Wubs, De Jong, Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution, Cancer Chemother. Pharmacol., 21, pp. 299-307, (1988)
[9]
Van Hoesel, Steerenberg, Vos, Hillen, Dormans, Antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin in the IgM solid immunocytoma-bearing Lou/M Wsl rat, J. Natl. Cancer Inst., 72, pp. 1141-1150, (1984)
[10]
De Jong, Steerenberg, Vos, Bulten, Verbeek, Kruizinga, Ruitenberg, Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethyl-cyclohexaneplatinum (II) sulfate, and of cis-diamminedichloroplatinum (II) in an immunocytoma model in the Lou/M rat, Cancer Res., 43, pp. 4927-4934, (1983)